Genevant Sciences
PrivateLast Round
Corporate Funding
Jul 31, 2020
Est. Valuation
$87.5M
Total Funding Raised
$40M
Company Overview
Genevant Sciences is a biotechnology company that provides nucleic acid delivery technology, including lipid nanoparticle (LNP) platforms, for the development of RNA-based therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genevant Sciences Comparables
Compare Genevant Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acuitas Therapeutics | 92% | |
| NanoVation Therapeutics | 88% | |
| Ethris | 77% |
Genevant Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 31, 2020 | ||||
| Seed | Apr 11, 2018 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2024
Monthly visitors increased 555% MoM, reaching 7.2K.
- Aug 13, 2023
Grew 18% QoQ from 40 to 47 employees.
Genevant Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genevant Sciences's valuation, stock price, and market status.
Is Genevant Sciences a public or private company?
Genevant Sciences is a private company.
What is the current stock price of Genevant Sciences?
Genevant Sciences is a private company with no public stock price. No recent secondary market data is available.
How much is Genevant Sciences worth (valuation)?
Genevant Sciences's valuation is estimated at $87.5M based on funding round data.
Can I buy Genevant Sciences stock?
Genevant Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genevant Sciences's last funding round?
Genevant Sciences's most recent funding round was Corporate Funding on April 11, 2018.
Who are the main investors in Genevant Sciences?
Investor information for Genevant Sciences is not publicly disclosed.
Will Genevant Sciences IPO soon?
No public IPO plans have been announced for Genevant Sciences.
How can I track Genevant Sciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genevant Sciences's secondary market activity and sign up for updates.